The devastating diagnosis of lung cancer in patients with COPD has led to some interesting observations such as the apparent higher sensitivity to immune checkpoint inhibitors (ICIs) in patients with both diseases compared to lung cancer alone. Speaking at TSANZSRS 2019 on the Gold Coast, Professor Ian Yang highlighted recent research that found in lung ...
Novel findings in lung cancer and COPD
By Mardi Chapman
23 Apr 2019